Article Text

This article has a correction. Please see:

Download PDFPDF
Extended report
Current evidence for the management of rheumatoid arthritis with biological disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of RA
  1. J L Nam1,
  2. K L Winthrop2,
  3. R F van Vollenhoven3,
  4. K Pavelka4,
  5. G Valesini5,
  6. E M A Hensor1,
  7. G Worthy6,
  8. R Landewé7,
  9. J S Smolen8,
  10. P Emery1,
  11. M H Buch1
  1. 1Section of Musculoskeletal Disease, Leeds Institute of Molecular Medicine, University of Leeds, Chapel Allerton Hospital, Leeds, UK
  2. 2Oregon Health and Science University, Portland, Oregon, USA
  3. 3Rheumatology Unit, Department of Medicine, Karolinska Institutet, Karolinska University Hospital, Solna, Sweden
  4. 4Institute of Rheumatology and Clinic of Rheumatology Charles University, Prague, Czech Republic
  5. 5Rheumatology Unit, Department of Clinical Medicine and Medical Therapy, Sapienza Università di Roma, Reumatologia, Policlinico Umberto I, Rome, Italy
  6. 6Clinical Trials Research Unit, University of Leeds, Leeds, UK
  7. 7Maastricht University Medical Center and CAPHRI Research Institute, Maastricht, The Netherlands
  8. 8Division of Rheumatology, Department of Medicine 3, Medical University of Vienna, Vienna General Hospital, Vienna, Austria
  1. Correspondence to Dr Maya H Buch, Section of Musculoskeletal Disease, Leeds Institute of Molecular Medicine, University of Leeds, 2nd Floor, Chapel Allerton Hospital, Chapeltown Road, Leeds LS7 4SA, UK; m.buch{at}leeds.ac.uk

Footnotes

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Competing interests None.

View Full Text

Statistics from Altmetric.com

Footnotes

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Competing interests None.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles

  • Miscellaneous
    BMJ Publishing Group Ltd and European League Against Rheumatism